Diversity in clinical trials matters for drug safety and efficacy—and for future medical advancements. Clinical trial ...

Geoffrey S. Ginsburg ( [email protected]) is director of the Duke Center for Applied Genomics and Precision Medicine, Duke University, in Durham, North Carolina. Kathryn A. Phillips is a professor of ...

Hirschsprung disease is a potentially fatal birth defect in which the enteric nervous system (ENS) is missing from the distal bowel Hirschsprung disease is defined by the absence of enteric neurons at ...

Precision medicine describes the definition of disease at a higher resolution by genomic and other technologies to enable more precise targeting of subgroups of disease with new therapies. Prominent ...

In a recent perspective published in Nature Medicine, the researcher shared his vision and future perspectives for the domains of clinical research and evidence-based therapeutics. In recent times, ...

The Department of Family Medicine is developing a program that trains physicians to provide high-quality, compassionate care to individuals experiencing homelessness and housing instability.

A research team led by the Department of Medicine, under the School of Clinical Medicine, LKS Faculty of Medicine of the University of Hong Kong (HKUMed), has synergised impacts of worldwide clinical ...

For every 1,000 patients in the study cohort, 497 (49.7%) are lost to precision oncology because of factors associated with getting biomarker test results. Among the 503 of 1,000 patients who did ...

As the use of artificial intelligence has spread rapidly throughout the US health care system, concerns have been raised about racial and ethnic biases built into the algorithms that often guide ...

Medical learners in the 21st century spend less time with patients during training than their counterparts did in the 20th century, which decreases the knowledge and practice of bedside clinical ...

Drexel University College of Medicine's clinical research program seeks to improve patient care through innovative approaches and new findings. By evaluating medicines, therapies and diagnostic tools, ...

Insilico Medicine("Insilico"), a clinical-stage biotechnology company driven by generative artificial intelligence (AI), today announces that the first patient has been dosed in a global multicenter ...